Caliper Expects Q4 Revenues to Exceed Guidance

Caliper Life Sciences' expected Q4 2009 revenues of $37.6 million exceeds the company's previous guidance of $33 to $35 million.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.